CXCL12 and stroke disorder: Brain SDF1-A level analysis (Figure 2B) demonstrated significant elevation at both 4 and 24 hours post stroke (113±7 pg/ml and 112±10 pg/ml, respectively; p<0.05 for both versus control 76±11 pg/ml).